About: LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.39 (-4.94%)
LTP ASX LTR Pharma Ltd
LTR Pharma Ltd share price
Atividade de preço de LTP
Último preço
$ 0,390
Variação (24h)
-0,02 AUD (4,94%)
Volume
600.33K
Volume (média 4 sem.)
-
Abertura
$ 0,41
Variação do dia
$ 0,37 - $ 0,41
Fechamento anterior
$ 0,41
Último negócio
20 Nov, 4:14 am GMT+0
Atrasado
20 Nov, 4:14 am GMT+0
LTP price performance
Atrasado
20 Nov, 4:14 am GMT+0
LTP details
quote.marketSignals